The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice

Biomaterials

Volumn 33, Issue 35, 2012, Pages 8995-9008

  Ji, Ru ^a,b   Zhang, Ning ^a   You, Nan ^a   Li, Qiang ^c   Liu, Weihui ^a,d   Jiang, Nan ^a   Liu, Jie ^a   Zhang, Hongtao ^a   Wang, Desheng ^a   Tao, Kaishan ^a   Dou, Kefeng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Differentiation; Extracellular matrix; Liver; Mesenchymal stem cell

Indexed keywords

BIO-SCAFFOLDS; BIOMATRIX; CELL MATURATION; CELL-BASED THERAPY; DECELLULARIZED; ENGRAFTMENT; EXTRACELLULAR MATRICES; GROWTH FACTOR; HEPATIC DIFFERENTIATION; HEPATIC STELLATE CELLS; HEPATOCYTES; LIVER DISEASE; LIVER TISSUE ENGINEERING; MESENCHYMAL STEM CELL; PARACRINE; RAT LIVERS; TRANSPLANTED CELLS;

CELL CULTURE; CELL PROLIFERATION; DIFFERENTIATION (CALCULUS); DISEASE CONTROL; FLOWCHARTING; LIVER; MAMMALS; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

CARBON TETRACHLORIDE; GROWTH FACTOR; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL ULTRASTRUCTURE; EXTRACELLULAR MATRIX; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STELLATE CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEPATOCYTES; LIVER; LIVER DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; RATS; RATS, INBRED F344; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

MURINAE; MUS; RATTUS;

EID: 84867141922     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.058     Document Type: Article

References (48)

1. Moreno R., Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006, 5:77-85.
2. Nussler A., Konig S., Ott M., Sokal E., Christ B., Thasler W., et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006, 45:144-159.
3. Vosough M., Moslem M., Pournasr B., Baharvand H. Cell-based therapeutics for liver disorders. Br Med Bull 2011, 100:157-172.
4. Zamule S.M., Coslo D.M., Chen F., Omiecinski C.J. Differentiation of human embryonic stem cells along a hepatic lineage. Chem Biol Interact 2011, 190:62-72.
5. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004, 40:1275-1284.
6. Zhao W., Li J.J., Cao D.Y., Li X., Zhang L.Y., He Y., et al. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol 2012, 18:1048-1058.
7. Subramanian K., Owens D.J., O'Brien T.D., Verfaillie C.M., Hu W.S. Enhanced differentiation of adult bone marrow-derived stem cells to liver lineage in aggregate culture. Tissue Eng Part A 2011, 17:2331-2341.
8. Parekkadan B., Milwid J.M. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 2010, 12:87-117.
9. Zomorodian E., Baghaban Eslaminejad M. Mesenchymal stem cells as a potent cell source for bone regeneration. Stem Cells Int 2012, 2012:980353.
10. Zhao D.C., Lei J.X., Chen R., Yu W.H., Zhang X.M., Li S.N., et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005, 11:3431-3440.
11. Piryaei A., Valojerdi M.R., Shahsavani M., Baharvand H. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev 2011, 7:103-118.
12. Peng L., Xie D.Y., Lin B.L., Liu J., Zhu H.P., Xie C., et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011, 54:820-828.
13. Burdick J.A., Vunjak-Novakovic G. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 2009, 15:205-219.
14. Hwang N.S., Varghese S., Elisseeff J. Controlled differentiation of stem cells. Adv Drug Deliv Rev 2008, 60:199-214.
15. Tian H., Bharadwaj S., Liu Y., Ma H., Ma P.X., Atala A., et al. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials 2010, 31:870-877.
16. Kazemnejad S., Allameh A., Soleimani M., Gharehbaghian A., Mohammadi Y., Amirizadeh N., et al. Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. J Gastroenterol Hepatol 2009, 24:278-287.
17. Uygun B.E., Soto-Gutierrez A., Yagi H., Izamis M.L., Guzzardi M.A., Shulman C., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010, 16:814-820.
18. Bao J., Shi Y., Sun H., Yin X., Yang R., Li L., et al. Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant 2011, 20:753-766.
19. Baptista P.M., Siddiqui M.M., Lozier G., Rodriguez S.R., Atala A., Soker S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011, 53:604-617.
20. Ng S.L., Narayanan K., Gao S., Wan A.C. Lineage restricted progenitors for the repopulation of decellularized heart. Biomaterials 2011, 32:7571-7580.
21. Wang Y., Cui C.B., Yamauchi M., Miguez P., Roach M., Malavarca R., et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 2011, 53:293-305.
22. Sun F., Zhou K., Mi W.J., Qiu J.H. Combined use of decellularized allogeneic artery conduits with autologous transdifferentiated adipose-derived stem cells for facial nerve regeneration in rats. Biomaterials 2011, 32:8118-8128.
23. Akhyari P., Aubin H., Gwanmesia P., Barth M., Hoffmann S., Huelsmann J., et al. The quest for an optimized protocol for whole-heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue Eng Part C Methods 2011, 17:915-926.
24. Liu W.H., Tao K.S., You N., Liu Z.C., Zhang H.T., Dou K.F. Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells. PLoS One 2011, 6:e23311.
25. Sailon A.M., Allori A.C., Davidson E.H., Reformat D.D., Allen R.J., Warren S.M. A novel flow-perfusion bioreactor supports 3D dynamic cell culture. J Biomed Biotechnol 2009, 2009:873816.
26. Jeong W.I., Park O., Radaeva S., Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 2006, 44:1441-1451.
27. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
28. Petersen T.H., Calle E.A., Zhao L., Lee E.J., Gui L., Raredon M.B., et al. Tissue-engineered lungs for in vivo implantation. Science 2010, 329:538-541.
29. Nakayama K.H., Batchelder C.A., Lee C.I., Tarantal A.F. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A 2010, 16:2207-2216.
30. Yang B., Zhang Y., Zhou L., Sun Z., Zheng J., Chen Y., et al. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng Part C Methods 2010, 16:1201-1211.
31. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32:3233-3243.
32. Yi W., Sun Y., Wei X., Gu C., Dong X., Kang X., et al. Proteomic profiling of human bone marrow mesenchymal stem cells under shear stress. Mol Cell Biochem 2010, 341:9-16.
33. Cartmell S.H., Porter B.D., Garcia A.J., Guldberg R.E. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng 2003, 9:1197-1203.
34. Holtorf H.L., Jansen J.A., Mikos A.G. Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A 2005, 72:326-334.
35. Chun S.Y., Lim G.J., Kwon T.G., Kwak E.K., Kim B.W., Atala A., et al. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 2007, 28:4251-4256.
36. Park J.S., Chu J.S., Tsou A.D., Diop R., Tang Z., Wang A., et al. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-beta. Biomaterials 2011, 32:3921-3930.
37. Kniazeva E., Kachgal S., Putnam A.J. Effects of extracellular matrix density and mesenchymal stem cells on neovascularization in vivo. Tissue Eng Part A 2011, 17:905-914.
38. Russo F.P., Alison M.R., Bigger B.W., Amofah E., Florou A., Amin F., et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006, 130:1807-1821.
39. di Bonzo L.V., Ferrero I., Cravanzola C., Mareschi K., Rustichell D., Novo E., et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008, 57:223-231.
40. Mohsin S., Shams S., Ali Nasir G., Khan M., Javaid Awan S., Khan S.N., et al. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation 2011, 81:42-48.
41. Aurich I., Mueller L.P., Aurich H., Luetzkendorf J., Tisljar K., Dollinger M.M., et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007, 56:405-415.
42. Hwang S., Hong H.N., Kim H.S., Park S.R., Won Y.J., Choi S.T., et al. Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis. Cell Biol Int 2012, 36:279-288.
43. Oyagi S., Hirose M., Kojima M., Okuyama M., Kawase M., Nakamura T., et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 2006, 44:742-748.
44. Belema-Bedada F., Uchida S., Martire A., Kostin S., Braun T. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2008, 2:566-575.
45. Li C., Kong Y., Wang H., Wang S., Yu H., Liu X., et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 2009, 50:1174-1183.
46. Kawai K., Xue F., Takahara T., Kudo H., Yata Y., Zhang W., et al. Matrix metalloproteinase-9 contributes to the mobilization of bone marrow cells in the injured liver. Cell Transplant 2012, 21:453-464.
47. Miyata E., Masuya M., Yoshida S., Nakamura S., Kato K., Sugimoto Y., et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 2008, 111:2427-2435.
48. Tai B.C., Du C., Gao S., Wan A.C., Ying J.Y. The use of a polyelectrolyte fibrous scaffold to deliver differentiated hMSCs to the liver. Biomaterials 2010, 31:48-57.